---
title: "This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289790435.md"
description: "Top Wall Street analysts initiated coverage on several stocks with bullish outlooks. BTIG rated ICU Medical (ICUI) a Buy with a $170 target. HC Wainwright & Co. gave Biodesix (BDSX) a Buy rating and a $26 target. Needham initiated Ceva (CEVA) with a Buy and $55 target. Evercore ISI rated Lincoln International (LCLN) In-Line at $25, while JP Morgan gave ESCO Technologies (ESE) an Overweight rating with a $420 target."
datetime: "2026-06-15T13:15:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289790435.md)
  - [en](https://longbridge.com/en/news/289790435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289790435.md)
---

# This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   BTIG analyst Sam Eiber initiated coverage on **ICU Medical Inc** (NASDAQ:ICUI) with a Buy rating and announced a price target of $170. ICU Medical shares closed at $142.20 on Friday. See how other analysts view this stock.
-   HC Wainwright & Co. analyst Yi Chen initiated coverage on **Biodesix Inc** (NASDAQ:BDSX) with a Buy rating and announced a price target of $26. Biodesix shares closed at $15.06 on Friday. See how other analysts view this stock.
-   Needham analyst Charles Shi initiated coverage on **Ceva Inc** (NASDAQ:CEVA) with a Buy rating and announced a price target of $55. CEVA shares closed at $46.03 on Friday. See how other analysts view this stock.
-   Evercore ISI Group analyst Benjamin Rubin initiated coverage on **Lincoln International Inc** (NYSE:LCLN) with an In-Line rating and announced a price target of $25. Lincoln International shares closed at $24.84 on Friday. See how other analysts view this stock.
-   JP Morgan analyst Tomohiko Sano initiated coverage on **ESCO Technologies Inc** (NYSE:ESE) with an Overweight rating and announced a price target of $420. ESCO Technologies shares closed at $313.74 on Friday. See how other analysts view this stock.

Considering buying ICUI stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [LCLN.US](https://longbridge.com/en/quote/LCLN.US.md)
- [BDSX.US](https://longbridge.com/en/quote/BDSX.US.md)
- [ICUI.US](https://longbridge.com/en/quote/ICUI.US.md)
- [CEVA.US](https://longbridge.com/en/quote/CEVA.US.md)
- [ESE.US](https://longbridge.com/en/quote/ESE.US.md)

## Related News & Research

- [Bank of New York Mellon Corp Trims Stock Position in ICU Medical, Inc. $ICUI](https://longbridge.com/en/news/294167750.md)
- [Is CEVA (CEVA) Above Fair Value After a 73% Rally?](https://longbridge.com/en/news/293798206.md)
- [Sei Investments Co. Grows Position in ESCO Technologies Inc. $ESE](https://longbridge.com/en/news/294179220.md)
- [Biodesix (BDSX) to Post Earnings on Wednesday](https://longbridge.com/en/news/294223037.md)
- [08:20 ETEbix Health Expands Medical Content and Coding Capabilities](https://longbridge.com/en/news/294206575.md)